BackClearside Biomedical Overview

Clearside Biomedical Intangible Assets

Clearside Biomedical's intangible assets is $0.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$0.00

Peer average

Loading

Clearside Biomedical Intangible Assets History

Loading

Clearside Biomedical vs. peers: Intangible Assets Comparison

Loading

Clearside Biomedical Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Clearside Biomedical (CLSD) FAQ

Clearside Biomedical (CLSD) currently reports a intangible assets of $0 as of September 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Clearside Biomedical's intangible assets history and peer comparisons.

Clearside Biomedical's intangible assets changed from $0 to $0 (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clearside Biomedical reported $0 in intangible assets as of September 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clearside Biomedical, and consider following CLSD for alerts when major investors trade the stock.

Clearside Biomedical is classified in the Healthcare sector. On intangible assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLSD with unrelated industries.